Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Swedish Orphan Biovitrum AB (publ)
  6. Financials
    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-09-30 am EDT
215.60 SEK   +0.89%
09/30Sobi - New number of shares and votes in Swedish Orphan Biovitrum AB
AQ
09/30New number of shares and votes in Swedish Orphan Biovitrum AB (publ)
AQ
09/16ADC Therapeutics, Sobi Say CHMP Opinion Positive for Zynlonta for Relapsed or Refractory Diffuse Large B-cell Lymphoma
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 45 43748 34554 63163 816--
Enterprise Value (EV)1 61 16162 09364 13170 75567 16563 401
P/E ratio 13,8x15,2x20,5x27,4x19,5x15,0x
Yield ------
Capitalization / Revenue 3,19x3,17x3,52x3,52x3,29x3,01x
EV / Revenue 4,29x4,07x4,13x3,90x3,46x2,99x
EV / EBITDA 9,99x9,09x11,2x12,4x10,3x8,32x
Price to Book 2,74x2,42x2,46x2,50x2,21x1,91x
Nbr of stocks (in thousands) 294 091291 059295 145295 991--
Reference price (SEK) 155166185216216216
Announcement Date 02/13/202002/18/202102/10/2022---
1 SEK in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 14 24815 26115 52918 13719 40321 177
EBITDA1 6 1216 8305 7405 7096 5237 620
Operating profit (EBIT)1 4 5334 8183 7333 7734 6595 840
Operating Margin 31,8%31,6%24,0%20,8%24,0%27,6%
Pre-Tax Profit (EBT)1 4 2474 2173 2952 9234 1365 365
Net income1 3 3043 2452 6792 3323 2784 259
Net margin 23,2%21,3%17,3%12,9%16,9%20,1%
EPS2 11,210,99,037,8711,114,4
Dividend per Share2 ------
Announcement Date 02/13/202002/18/202102/10/2022---
1 SEK in Million
2 SEK
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 4 8964 9253 8763 9365 3035 017
EBITDA1 2 0611 4619971 0891 8522 045
Operating profit (EBIT)1 1 5251 4374235781 7631 483
Operating Margin 31,1%29,2%10,9%14,7%33,3%29,6%
Pre-Tax Profit (EBT)1 1 4236743174481 6881 415
Net income1 1 2415432583771 3331 093
Net margin 25,3%11,0%6,66%9,57%25,1%21,8%
EPS2 4,181,830,861,194,563,70
Dividend per Share ------
Announcement Date 02/10/202204/28/202207/19/2022---
1 SEK in Million
2 SEK
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 15 72413 7489 5006 9403 349-
Net Cash position1 -----415
Leverage (Debt / EBITDA) 2,57x2,01x1,66x1,22x0,51x-0,05x
Free Cash Flow1 -18 0511 2505 1032 9224 3304 802
ROE (Net Profit / Equities) 25,4%17,5%12,3%10,3%11,9%13,5%
Shareholders' equity1 12 98518 56821 70422 56827 65931 444
ROA (Net Profit / Asset) 10,5%6,91%5,53%4,76%6,21%7,45%
Assets1 31 42246 97048 47248 98452 75857 185
Book Value Per Share2 56,468,575,186,297,5113
Cash Flow per Share2 12,317,518,411,515,616,7
Capex1 37,041,047,049,062,784,0
Capex / Sales 0,26%0,27%0,30%0,27%0,32%0,40%
Announcement Date 02/13/202002/18/202102/10/2022---
1 SEK in Million
2 SEK
Previous periodNext period
Estimates
Key data
Capitalization (SEK) 63 815 648 173
Capitalization (USD) 5 746 543 075
Net sales (SEK) 15 529 000 000
Net sales (USD) 1 398 372 812
Number of employees 1 554
Sales / Employee (SEK) 9 992 921
Sales / Employee (USD) 899 854
Free-Float 57,8%
Free-Float capitalization (SEK) 36 883 639 535
Free-Float capitalization (USD) 3 321 339 349
Avg. Exchange 20 sessions (SEK) 104 016 166
Avg. Exchange 20 sessions (USD) 9 366 564
Average Daily Capital Traded 0,16%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA